{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T17:10:04Z","timestamp":1784826604462,"version":"3.55.0"},"reference-count":27,"publisher":"JLE","issue":"2","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.nephro.2018.08.004","type":"journal-article","created":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T14:39:25Z","timestamp":1547649565000},"page":"110-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Interest of therapeutic drug monitoring of aminoglycosides administered by a monodose regimen"],"prefix":"10.1684","volume":"15","author":[{"given":"Haifa","family":"Ben Romdhane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Ben Fredj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amel","family":"Chaabane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana","family":"Ben Aicha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohra","family":"Chadly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najeh","family":"Ben Fadhel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naceur","family":"Boughattas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Aouam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"18929","reference":[{"key":"10.1016\/j.nephro.2018.08.004_bib0140","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.drup.2010.08.003","article-title":"Aminoglycoside modifying enzymes","volume":"13","author":"Ramirez","year":"2010","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.nephro.2018.08.004_bib0145","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1136\/archdischild-2015-309069","article-title":"What do I need to know about aminoglycoside antibiotics?","volume":"102","author":"Germovsek","year":"2017","journal-title":"Arch Dis Child Educ Pract Ed"},{"key":"10.1016\/j.nephro.2018.08.004_bib0150","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ijantimicag.2016.10.022","article-title":"Determinants of gentamicin concentrations in critically ill patients: a population pharmacokinetic analysis","volume":"49","author":"Hodiamont","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.nephro.2018.08.004_bib0155","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s40262-016-0428-x","article-title":"Amikacin in critically ill patients: a review of population Pharmacokinetic Studies","volume":"56","author":"Marsot","year":"2017","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.nephro.2018.08.004_bib0160","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1046\/j.1365-2125.1999.00850.x","article-title":"The therapeutic monitoring of antimicrobial agents","volume":"47","author":"Begg","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.nephro.2018.08.004_bib0165","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1093\/clinids\/14.1.320","article-title":"A critical reevaluation of the \u201ctherapeutic range\u201d of aminoglycosides","volume":"14","author":"McCormack","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.nephro.2018.08.004_bib0170","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1177\/0897190014546102","article-title":"Aminoglycoside-induced nephrotoxicity\u00a0\u2013 a focus on monitoring: a review of literature","volume":"27","author":"Destache","year":"2014","journal-title":"J Pharm Pract"},{"key":"10.1016\/j.nephro.2018.08.004_bib0175","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2165\/00003088-199936020-00001","article-title":"Once daily aminoglycoside therapy. Is it less toxic than multiple daily doses and how should it be monitored?","volume":"36","author":"Barclay","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.nephro.2018.08.004_bib0180","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1177\/0091270004266633","article-title":"Application of Bayes theorem to aminoglycoside-associated nephrotoxicity: comparison of extended interval dosing, individualized pharmacokinetic monitoring, and multiple-daily dosing","volume":"44","author":"Kim","year":"2004","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.nephro.2018.08.004_bib0185","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.2146\/ajhp140564","article-title":"Once-daily aminoglycoside dosing: an update on current literature","volume":"72","author":"Stankowicz","year":"2015","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.nephro.2018.08.004_bib0190","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2515\/therapie\/2011001","article-title":"Niveau de preuve du suivi th\u00e9rapeutique pharmacologique des aminosides","volume":"66","author":"Venisse","year":"2011","journal-title":"Therapie"},{"key":"10.1016\/j.nephro.2018.08.004_bib0195","doi-asserted-by":"crossref","first-page":"e6354","DOI":"10.1136\/bmj.e6354","article-title":"Monitoring aminoglycoside level","volume":"345","author":"Banerjee","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.nephro.2018.08.004_bib0200","doi-asserted-by":"crossref","first-page":"e7264","DOI":"10.1136\/bmj.e7264","article-title":"No evidence base for monitoring aminoglycoside levels","volume":"345","author":"McCormack","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.nephro.2018.08.004_bib0205","article-title":"Suivi th\u00e9rapeutique pharmacologique de l\u2019amikacine","author":"Lacarelle","year":"2003","journal-title":"Biologie m\u00e9dicale"},{"key":"10.1016\/j.nephro.2018.08.004_bib0210","first-page":"143","article-title":"Accuracy of Bayesian and Sawchuk-Zaske dosing methods for gentamicin","volume":"5","author":"Burton","year":"1986","journal-title":"Clin Pharm"},{"key":"10.1016\/j.nephro.2018.08.004_bib0215","doi-asserted-by":"crossref","first-page":"R165","DOI":"10.1186\/cc12844","article-title":"Therapeutic drug monitoring of amikacin in septic patients","volume":"17","author":"Duszynska","year":"2013","journal-title":"Crit Care"},{"key":"10.1016\/j.nephro.2018.08.004_bib0220","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1128\/AAC.39.3.650","article-title":"Experience with a once-daily aminoglycoside program administered to 2,184\u00a0adult patients","volume":"39","author":"Nicolau","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.nephro.2018.08.004_bib0225","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/bmj.312.7027.338","article-title":"Single or multiple daily doses of aminoglycosides: a meta-analysis","volume":"312","author":"Barza","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.nephro.2018.08.004_bib0230","doi-asserted-by":"crossref","first-page":"953","DOI":"10.3109\/00365548.2011.601755","article-title":"Short-term gentamicin therapy and risk of renal toxicity in patients with bacteraemia","volume":"43","author":"Spanggaard","year":"2011","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.nephro.2018.08.004_bib0235","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/FTD.0000000000000107","article-title":"Gentamicin and renal function: lessons from 15\u00a0years\u2019 experience of a pharmacokinetic service for extended interval dosing of gentamicin","volume":"37","author":"Plajer","year":"2015","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.nephro.2018.08.004_bib0240","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0002-9343(02)01476-6","article-title":"Pharmacokinetic dosing of aminoglycosides: A controlled trial","volume":"114","author":"Bartal","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.nephro.2018.08.004_bib0245","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1592\/phco.21.5.443.34490","article-title":"Individualized pharmacokinetic monitoring results in less aminoglycoside associated nephrotoxicity and fewer associated costs","volume":"21","author":"Streetman","year":"2001","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.nephro.2018.08.004_bib0250","first-page":"1135","article-title":"Aminoglycosides for life-threatening infections: a plea for an individualized approach using intensive therapeutic drug monitoring","volume":"80","author":"De Waele","year":"2014","journal-title":"Minerva Anestesiol"},{"key":"10.1016\/j.nephro.2018.08.004_bib0255","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1093\/clinids\/14.1.320","article-title":"A critical reevaluation of the \u201ctherapeutic range\u201d of aminoglycosides","volume":"14","author":"McCormack","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.nephro.2018.08.004_bib0260","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1128\/AAC.21.5.721","article-title":"Clinical and pharmacokinetic characteristics of aminoglycoside nephrotoxicity in 20\u00a0I critically ill patients","volume":"21","author":"Schentag","year":"1982","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.nephro.2018.08.004_bib0265","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/FTD.0000000000000283","article-title":"Extended interval dosing of gentamicin aiming for a drug-free period in neonates: a prospective cohort study","volume":"38","author":"Van Maarseveen","year":"2016","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.nephro.2018.08.004_bib0270","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2125.1989.tb03503.x","article-title":"Comparison of Sawchuk-Zaske and Bayesian forecasting for aminoglycosides in seriously ill patients","volume":"28","author":"Denaro","year":"1989","journal-title":"Br J Clin Pharmacol"}],"container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725518306503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725518306503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jle.com\/10.1016\/j.nephro.2018.08.004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T16:17:13Z","timestamp":1741191433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769725518306503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S1769725518306503"],"URL":"https:\/\/doi.org\/10.1016\/j.nephro.2018.08.004","relation":{},"ISSN":["1769-7255"],"issn-type":[{"value":"1769-7255","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interest of therapeutic drug monitoring of aminoglycosides administered by a monodose regimen","name":"articletitle","label":"Article Title"},{"value":"N\u00e9phrologie & Th\u00e9rapeutique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nephro.2018.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Soci\u00e9t\u00e9 francophone de n\u00e9phrologie, dialyse et transplantation. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}